• Profile
Close

A single session of hyperbaric oxygen therapy demonstrates acute and long-lasting neuroplasticity effects in humans: A replicated, randomized controlled clinical trial

Journal of Pain Research Aug 03, 2019

Wahl AM, et al. - Given their previous work demonstrating a long-lasting neuroplasticity effect mitigating the burn injury (BI)-induced secondary hyperalgesia areas (SHA)-response in the hyperbaric oxygen therapy (HBOT)-preconditioned group of BI model, researchers sought to confirm these findings via conducting an examiner-blinded, block-randomized, controlled, crossover study including 19 healthy individuals. Two BI-sessions were attended by the individuals; inter-session interval was of ≥ 28 days. Using a contact thermode (12.5 cm2, 47C°, 420 s), BIs were induced on the lower legs of the participants. They block-randomized the participants to receive HBOT (2.4 ATA, 100% O2, 90 min) or ambient conditions ([AC]; 1 ATA, 21% O2), dividing cohorts equally into two sequence allocations: HBOT-AC or AC-HBOT. Outcome data establish an association of a single HBOT-session vs control with both acute and long-lasting mitigating effects on BI-induced SHA. This confirms that hyperbaric oxygen therapy has central anti-inflammatory, neuroplasticity effects.
Full text available Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay